United States · FDA National Drug Code directory
CETIRIZINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61037-480_5a1df22c-40c4-6cf1-e063-6294a90ad7f7
- Product NDC
- 61037-480
- Form
- SOLUTION
- Composition / generic term
- Cetirizine Hydrochloride
- Labeler
- BAJAJ MEDICAL, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250508
- Source listing expiry
- 20271231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 120 mL in 1 BOTTLE, PLASTIC (61037-480-22) · 61037-480-22
- 480 mL in 1 BOTTLE, PLASTIC (61037-480-23) · 61037-480-23
- 240 mL in 1 BOTTLE, PLASTIC (61037-480-24) · 61037-480-24
- 5 mL in 1 CUP, UNIT-DOSE (61037-480-26) · 61037-480-26
- 5 mL in 1 BOX, UNIT-DOSE (61037-480-32) · 61037-480-32
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →